Pfizer’s vaccine offers partial protection against micron

• GSK advances the effectiveness of its therapy against micron
  

• The micron variant could account for half the infections in Europe in a few months
  

A booster dose could provide additional protection against this new variant, according to the South African health authorities.

The vaccine Pfizer offers a partial protection versus micron, the variant of the coronavirus discovered in South Africa. This is pointed out by the first study carried out in the country to verify the level of effectiveness of the current vaccines that exist against the Covid-19, to which you have had access Bloomberg.

According to Alex Sigal, a researcher at the African Health Research Institute, the ability to micron to evade immunity induced by vaccines and infections it is “robust but not complete”. Therefore, he believes that a booster dose could provide additional protection to the population.

The result of this first study is released after the main White House epidemiologist, Anthony Fauci, said Tuesday that there are indications that micron could cause a disease “less serious” than the delta variant.

“It seems that the cases we are seeing do not have a serious profile of the disease, in fact, they could, and I reiterate that ‘they could’, indicate less seriousness, as shown the proportion of hospitalizations in the face of new cases, “said Fauci, who apart from relying on data coming out of the US, made reference to those from South Africa.

The CEO of Pfizer, Albert Bourla, also pointed out today during his speech at a forum organized by The Wall Street Journal that micron seemed to generate less severe symptoms than other variants, but he remarked his concern for its high transmission capacity. “I don’t think it’s good news to have something that spreads quickly,” he said.

The manager added that the company is investigating the level of protection offered by its vaccine against this variant. I trusted to have additional information in the next few weeks, but did not elaborate. I know you said you were hopeful that the U.S. Food and Drug Administration (FDA) would approve the use of the pills this month. Paxlovid, which aims to become the first oral treatment for patients with covid-19 in the country.

– .